Huang, Y., & Tsai, T. (2019). Remission Duration and Long-Term Outcomes in Patients with Moderate-to-Severe Psoriasis Treated by Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center Experience. Dermatol Ther (Heidelb).
استشهاد بنمط شيكاغوHuang, Yi-Wei, و Tsen-Fang Tsai. "Remission Duration and Long-Term Outcomes in Patients With Moderate-to-Severe Psoriasis Treated By Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center Experience." Dermatol Ther (Heidelb) 2019.
MLA استشهادHuang, Yi-Wei, و Tsen-Fang Tsai. "Remission Duration and Long-Term Outcomes in Patients With Moderate-to-Severe Psoriasis Treated By Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center Experience." Dermatol Ther (Heidelb) 2019.